Zug, Zug, Switzerland OCCIDENT is the famous VC, which was founded in 1993. The fund was located in Europe if to be more exact in Switzerland. The main office of represented VC is situated in the Zug.
The important activity for fund was in 2018. Speaking about the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 5 - 10 millions dollars.
The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is no match between the location of its establishment and the land of its numerous investments - Germany. Among the various public portfolio startups of the fund, we may underline advanceCOR, iThera Medical, Implandata Ophthalmic Products Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Diagnostics, Pharmaceutical.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the OCCIDENT, startups are often financed by Venture Kick, Zu00fcrcher Kantonal Bank, High-Tech Gru00fcnderfonds. The meaningful sponsors for the fund in investment in the same round are Zu00fcrcher Kantonal Bank, High-Tech Gru00fcnderfonds, KfW. In the next rounds fund is usually obtained by Zu00fcrcher Kantonal Bank, Eurostars, Alpana Ventures.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Antenna Group | California, San Francisco, United States |
| Bodhtree Consulting Ltd | California, Santa Clara, United States |
| BRANDED STRATEGIC ADVISORS | New York, New York, United States |
| Bridge Investments | - |
| CDAM | England, London, United Kingdom |
| CN-Healthcare | Beijing, China, Haidian |
| Falcon Partners | New Jersey, Roseland, United States |
| Hatzimemos / Libby | New York, New York, United States |
| ITC Holdings | Michigan, Novi, United States |
| Jinyu Touzi | China, Songjiang, Songjiang District |
| Jynwel Capital | China, Hong Kong, Hong Kong Island |
| Nanjing Qingfang Touzi | China, Jiangsu, Nanjing |
| RACSeedSpark | - |
| Robolution Capital | France, Ile-de-France, Paris |
| Southern Pacific Capital Group | Florida, Melbourne, United States |
| Space Florida | Florida, Merritt Island, United States |
| Stone-Goff Partners | Boston, Massachusetts, United States |
| Undercurrent | New York, New York, United States |
| W3 Digital Agency | Argentina, Buenos Aires, Distrito Federal |
| Zijinhui | Beijing, China, Haidian |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Lymphatica Medtech | 08 Oct 2024 | Vaud, Switzerland | |||
hemotune | $15M | 25 Mar 2024 | Zurich, Zurich, Switzerland | ||
Tubulis | $151M | 14 Mar 2024 | Munich, Bavaria, Germany | ||
Altavo | $5M | 20 Feb 2024 | Dresden, Sachsen, Germany | ||
Chipmetrics | $2M | 24 Jan 2024 | Joensuu, Eastern Finland, Finland | ||
ReCatalyst | $2M | 12 Jul 2023 | Ljubljana, Ljubljana Urban Commune, Slovenia | ||
EBAMed | $16M | 27 Jun 2023 | Geneva, Geneva, Switzerland | ||
Resistell AG | $9M | 20 Dec 2022 | Basel, Basel-City, Switzerland | ||
Core Sensing | $5M | 26 Sep 2022 | Darmstadt, Hessen, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Lymphatica Medtech | 08 Oct 2024 | Vaud, Switzerland | |||
hemotune | $15M | 25 Mar 2024 | Zurich, Zurich, Switzerland | ||
Tubulis | $151M | 14 Mar 2024 | Munich, Bavaria, Germany | ||
Altavo | $5M | 20 Feb 2024 | Dresden, Sachsen, Germany | ||
Chipmetrics | $2M | 24 Jan 2024 | Joensuu, Eastern Finland, Finland | ||
ReCatalyst | $2M | 12 Jul 2023 | Ljubljana, Ljubljana Urban Commune, Slovenia | ||
EBAMed | $16M | 27 Jun 2023 | Geneva, Geneva, Switzerland | ||
Resistell AG | $9M | 20 Dec 2022 | Basel, Basel-City, Switzerland | ||
Core Sensing | $5M | 26 Sep 2022 | Darmstadt, Hessen, Germany |
